Supreme Court calls on top government lawyer to weigh PCSK9 patent appeal
Another chapter in the PCSK9 battle of Amgen vs. Sanofi and Regeneron is afoot, with the Supreme Court calling on the federal government’s top lawyer to weigh in.
On Monday, SCOTUS invited the Solicitor General to file a brief expressing the views of the US on the patent case involving Amgen’s cholesterol drug Repatha as the court considers whether to hear the appeal of a ruling that invalidated Amgen’s patents for the drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.